scispace - formally typeset
W

Weijuan Huang

Researcher at Chinese Center for Disease Control and Prevention

Publications -  49
Citations -  1558

Weijuan Huang is an academic researcher from Chinese Center for Disease Control and Prevention. The author has contributed to research in topics: Virus & Neuraminidase. The author has an hindex of 17, co-authored 39 publications receiving 1278 citations. Previous affiliations of Weijuan Huang include National Health and Family Planning Commission & Centers for Disease Control and Prevention.

Papers
More filters
Journal Article

[Virological characteristics of influenza A (H3N2) virus in mainland China during 2013-2014].

TL;DR: Although the majority of circulating influenza A (H3N2) viruses in 2011-2012 season in Mainland China were antigeniclly matched by current influenza vaccine strain and the selected representative viruses, low reaction strains have increased since 2012, therefore it is necessary to strengthen the surveillance on the variation of influenza virus.
Journal ArticleDOI

Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China.

TL;DR: NAIs remain the recommended antiviral for treatment and prophylaxis of influenza virus infections during the 2016-2017 influenza season in Mainland China and will remain so during the 2017-18 season.
Journal ArticleDOI

Identification of Two Novel Candidate Genetic Variants Associated With the Responsiveness to Influenza Vaccination

TL;DR: Zhang et al. as mentioned in this paper found that the GG genotype of rs2455230 tended to be correlated with lower antibody fold rises (P = 0.096) against H3N2, but the difference was not statistically significant.
Journal ArticleDOI

Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice.

TL;DR: The authors in this article showed that the high frequency and good replication capacity of strains with reduced susceptibility to neuraminidase inhibitors (NAIs) in highly pathogenic avian influenza H7N9 (HPAI H7Ns9) virus made it a significance to further study its drug resistance.